NL6812681A - - Google Patents
Info
- Publication number
- NL6812681A NL6812681A NL6812681A NL6812681A NL6812681A NL 6812681 A NL6812681 A NL 6812681A NL 6812681 A NL6812681 A NL 6812681A NL 6812681 A NL6812681 A NL 6812681A NL 6812681 A NL6812681 A NL 6812681A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB40961/67A GB1199632A (en) | 1967-09-07 | 1967-09-07 | Alkanolamine Derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL6812681A true NL6812681A (OSRAM) | 1969-03-11 |
Family
ID=10417463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL6812681A NL6812681A (OSRAM) | 1967-09-07 | 1968-09-05 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3634511A (OSRAM) |
| JP (1) | JPS5212182B1 (OSRAM) |
| AT (3) | AT290502B (OSRAM) |
| BE (1) | BE720544A (OSRAM) |
| CA (1) | CA921917A (OSRAM) |
| CH (2) | CH565137A5 (OSRAM) |
| CS (1) | CS152306B2 (OSRAM) |
| DE (1) | DE1793358A1 (OSRAM) |
| ES (1) | ES357931A2 (OSRAM) |
| FR (1) | FR327F (OSRAM) |
| GB (1) | GB1199632A (OSRAM) |
| IE (1) | IE32287B1 (OSRAM) |
| IL (1) | IL30643A (OSRAM) |
| NL (1) | NL6812681A (OSRAM) |
| NO (1) | NO122074B (OSRAM) |
| SE (1) | SE353318B (OSRAM) |
| SU (1) | SU363241A3 (OSRAM) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4146558A (en) * | 1966-05-23 | 1979-03-27 | Sterling Drug Inc. | Azo dyestuff intermediate nitro- or aminobenzenes ring-substituted by a quaternized amine alkyl or amino-alkoxy group |
| ES373606A1 (es) * | 1968-11-18 | 1972-06-01 | Pfizer | Un procedimiento para la preparacion de nuevos derivados depropanolamina. |
| US3959486A (en) * | 1970-05-27 | 1976-05-25 | Imperial Chemical Industries Limited | Method for producing β-adrenergic blockage with alkanolamine derivatives |
| US4059622A (en) * | 1970-05-27 | 1977-11-22 | Imperial Chemical Industries Limited | Alkanolamine derivatives |
| US4206144A (en) * | 1971-11-22 | 1980-06-03 | Sterling Drug Inc. | N,N-Dialkyl-N-aminoalkyl-N-(amino or nitro)phenylalkyl- and N-methyl-N-[3-(amino or nitro)phenoxy-2-hydroxy-1-propyl]-N,N-bis(3-aminopropyl)quaternary ammonium salts |
| US3919424A (en) * | 1972-02-16 | 1975-11-11 | Mead Johnson & Co | Bronchodilator process and composition |
| US3864398A (en) * | 1972-05-01 | 1975-02-04 | Teikoku Hormone Mfg Co Ltd | Process for the preparation of acylamino alkanol derivatives |
| JPS5323826B2 (OSRAM) * | 1972-05-15 | 1978-07-17 | ||
| US4038414A (en) * | 1972-06-08 | 1977-07-26 | Ciba-Geigy Corporation | Amines and processes for their manufacture |
| US3993776A (en) * | 1973-10-15 | 1976-11-23 | Mead Johnson & Company | Anorexigenic process and composition |
| US3911007A (en) * | 1974-08-08 | 1975-10-07 | Searle & Co | N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides |
| MX158644A (es) * | 1982-07-20 | 1989-02-21 | Menarini Sas | Procedimiento para preparar un derivado 1-alquilamina-3-(4(p-alquiloxibenzamida)-fenoxi)-2propanol |
| FI832377A0 (fi) * | 1983-06-29 | 1983-06-29 | Star Oy Ab | Nytt foerfarande foer framstaellning av (r)-, (s)-eller (r,s)-1-(4'-alkylamido-2'-acetyl) fenoxi-3-alkylamino-2-propanoler |
| US5541204A (en) * | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
| UY24949A1 (es) * | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | Compuestos calcilíticos |
-
1967
- 1967-09-07 GB GB40961/67A patent/GB1199632A/en not_active Expired
-
1968
- 1968-08-19 IE IE1011/68A patent/IE32287B1/xx unknown
- 1968-08-21 US US754456A patent/US3634511A/en not_active Expired - Lifetime
- 1968-08-29 IL IL30643A patent/IL30643A/en unknown
- 1968-08-29 CA CA028836A patent/CA921917A/en not_active Expired
- 1968-09-05 DE DE19681793358 patent/DE1793358A1/de active Pending
- 1968-09-05 NL NL6812681A patent/NL6812681A/xx unknown
- 1968-09-06 BE BE720544D patent/BE720544A/xx unknown
- 1968-09-06 CH CH1155171A patent/CH565137A5/xx not_active IP Right Cessation
- 1968-09-06 JP JP43064014A patent/JPS5212182B1/ja active Pending
- 1968-09-06 CH CH1155071A patent/CH553156A/xx not_active IP Right Cessation
- 1968-09-06 CS CS6271A patent/CS152306B2/cs unknown
- 1968-09-06 NO NO3476/68A patent/NO122074B/no unknown
- 1968-09-06 SE SE12040/68A patent/SE353318B/xx unknown
- 1968-09-06 SU SU1270254A patent/SU363241A3/ru active
- 1968-09-07 ES ES357931A patent/ES357931A2/es not_active Expired
- 1968-09-09 AT AT877668A patent/AT290502B/de not_active IP Right Cessation
- 1968-09-09 AT AT192270A patent/AT289765B/de not_active IP Right Cessation
- 1968-09-09 AT AT192170A patent/AT291969B/de not_active IP Right Cessation
- 1968-12-05 FR FR327D patent/FR327F/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| SU363241A3 (OSRAM) | 1972-12-30 |
| SE353318B (OSRAM) | 1973-01-29 |
| AT290502B (de) | 1971-06-11 |
| ES357931A2 (es) | 1970-04-01 |
| JPS5212182B1 (OSRAM) | 1977-04-05 |
| GB1199632A (en) | 1970-07-22 |
| IL30643A (en) | 1973-01-30 |
| AT289765B (de) | 1971-05-10 |
| CH553156A (de) | 1974-08-30 |
| BE720544A (OSRAM) | 1969-03-06 |
| CH565137A5 (OSRAM) | 1975-08-15 |
| CA921917A (en) | 1973-02-27 |
| AT291969B (de) | 1971-08-10 |
| IE32287B1 (en) | 1973-06-13 |
| IL30643A0 (en) | 1968-10-24 |
| FR327F (OSRAM) | 1970-09-21 |
| DE1793358A1 (de) | 1972-11-09 |
| NO122074B (OSRAM) | 1971-05-18 |
| CS152306B2 (OSRAM) | 1973-12-19 |
| US3634511A (en) | 1972-01-11 |
| IE32287L (en) | 1969-03-07 |